Paltimatrectinib

Overview

Paltimatrectinib (compound I-147) is a potent tyrosine kinase inhibitor with an IC 50 of <10 nM for tropomyosin kinases A ( TrkA ). Paltimatrectinib has the potential for cancer and inflammatory diseases.

Application

Products | Products > Disease Areas > Pain | Products > Disease Areas > Neurological, Eye or Ear Disease | Products > Disease Areas > Cancer | Products > Disease Areas > Inflammation or Immune System Disease | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Signaling Pathways > Protein Tyrosine Kinase/RTK | Products > Signaling Pathways > Neuronal Signaling | Products > Research Areas > Inflammation/Immunology | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Signaling Pathways > Tyrosinase | Products > Signaling Pathways > Trk Receptor

Product Information

• Catalog No.: HY-145587
• CAS No.: 2353522-15-1
• Molecular Formula: C20H15F5N6
• Molecular Weight: 434.37
• Purity: 99.95%
• Storage: Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 6 months , -20°C, 1 month
• Availability: In-stock

Source

Original product source